HLA-DRA Antikörper (AA 28-232)
-
- Target Alle HLA-DRA Antikörper anzeigen
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Bindungsspezifität
- AA 28-232
-
Reaktivität
- Affe
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLA-DRA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (fixed cells) (IF/ICC)
- Aufreinigung
- Protein A + Protein G affinity chromatography
- Immunogen
- Glu28-Ile232
- Top Product
- Discover our top product HLA-DRA Primärantikörper
-
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-254) antibody
HLA-DRA Reaktivität: Human WB, FACS, ELISA, ICC Wirt: Maus Monoclonal 1C11A5 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-216) antibodyHLA-DRA Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 27-216) antibodyHLA-DRA Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 1-254) antibodyHLA-DRA Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human FACS, IHC, IF, StM Wirt: Maus Monoclonal 19-26-1-same as MB-26-1 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human IHC Wirt: Kaninchen Monoclonal MSVA-470R unconjugated Recombinant Antibody
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-221) antibodyHLA-DRA Reaktivität: Kaninchen WB, IHC, IP, ICC Wirt: Meerschweinchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 149-177), (C-Term) antibodyHLA-DRA Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB19527 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4 °C for frequent use. Aliquot and store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
-
- Target
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
- Andere Bezeichnung
- Major Histocompatibility Complex Class II DR alpha (HLA-DRA Produkte)
- Pathways
- T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-
